Amgen Inc.
USD355.20
+1.14 (+0.32%)
CEO
Robert A. Bradway
IPO Date
1983-06-17
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
US
Open
$357.66
Prev. Close
$354.06
Day Low
$351.96
Day High
$358.17
52W Low
$267.83
52W High
$391.29
Market Cap
$191.70B
Volume
2.73M
| 34.5 |
| 31 Dec 2023 | FY | 70.1% | 23.8% | 107.8% | 6.9% | 10.37 | 1.65 | 22.9 |
| 31 Dec 2022 | FY | 75.7% | 24.9% | 179.0% | 10.1% | 10.64 | 1.41 | 21.6 |
| 31 Dec 2021 | FY | 75.2% | 22.7% | 88.0% | 9.6% | 4.97 | 1.59 | 21.8 |
| 31 Dec 2020 | FY | 75.8% | 28.6% | 77.2% | 11.5% | 3.51 | 1.81 | 18.5 |
| 31 Dec 2019 | FY | 81.4% | 33.6% | 81.1% | 13.1% | 3.09 | 1.44 | 18.6 |
| 31 Dec 2018 | FY | 82.7% | 35.3% | 67.2% | 12.6% | 2.71 | 2.79 | 15.3 |
| 31 Dec 2017 | FY | 82.2% | 8.7% | 7.8% | 2.5% | 1.40 | 5.49 | 64.2 |
| 31 Dec 2016 | FY | 81.9% | 33.6% | 25.8% | 9.9% | 1.16 | 4.11 | 14.2 |
| 33.1 |
| 30 Sept 2025 | Q3 | 67.8% | 33.7% | 33.4% | 3.6% | 5.67 | 1.28 | 11.8 |
| 30 Jun 2025 | Q2 | 67.2% | 15.6% | 19.3% | 1.6% | 7.57 | 1.31 | 26.2 |
| 31 Mar 2025 | Q1 | 63.6% | 21.2% | 27.9% | 1.9% | 9.24 | 1.17 | 24.2 |
| 31 Dec 2024 | Q4 | 65.7% | 6.9% | 10.7% | 0.7% | 10.23 | 1.26 | 56.2 |
| 30 Sept 2024 | Q3 | 61.1% | 33.3% | 37.6% | 3.1% | 8.02 | 1.32 | 15.3 |
| 30 Jun 2024 | Q2 | 61.4% | 8.9% | 12.6% | 0.8% | 10.57 | 1.26 | 56.0 |
| 31 Mar 2024 | Q1 | 57.0% | -1.5% | -2.3% | -0.1% | 12.75 | 1.42 | -335.6 |
| 31 Dec 2023 | Q4 | 62.0% | 9.4% | 12.3% | 0.8% | 10.37 | 1.65 | 50.2 |